世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

アプレピタント注射剤の世界市場レポート、歴史と予測2018-2029年、メーカー別内訳データ、主要地域別、タイプ別、用途別


Global Aprepitant Injection Market Report, History and Forecast 2018-2029, Breakdown Data by Manufacturers, Key Regions, Types and Application

アレピダン注射剤は、アレピダンを大豆油で包んだサブミクロン乳剤である。経口製剤と比較して、バイオアベイラビリティ(生物学的利用能)と服薬コンプライアンスを大幅に改善することができ、同時に、類似の注... もっと見る

 

 

出版社 出版年月 電子版価格 言語
QYResearch
QYリサーチ
2023年11月2日 US$3,350
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら
英語

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。

日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


 

サマリー

アレピダン注射剤は、アレピダンを大豆油で包んだサブミクロン乳剤である。経口製剤と比較して、バイオアベイラビリティ(生物学的利用能)と服薬コンプライアンスを大幅に改善することができ、同時に、類似の注射製剤の臨床使用におけるアナフィラキシーの発生率を効果的に減少させることができる。化学療法による悪心・嘔吐の処方薬である。単独または他の薬剤と併用することができる。

QYResearch発行のAprepitant Injectionに関する調査レポートは、COVID-19とロシア・ウクライナ戦争が2022年の市場に二重の影響を与えることを明らかにしている。Aprepitant Injectionの世界市場は、2023年から2029年の間に年平均成長率%で、2022年の100万米ドルから増加し、2029年には100万米ドルに達すると予測されています。癌治療センターと病院からの需要が業界の主要な推進力である。
北米、ヨーロッパ、アジア太平洋地域は、アプレピタント注射剤産業の主要地域である。これらの地域の中で、川下産業からの旺盛な需要に刺激され、アジア太平洋地域は2023年から2029年の間にCAGR %で急成長を遂げると推定されている。

世界的に、Aprepitant Injectionの主要メーカーには、Heron Therapeutics, Inc.やQilu Pharmaceuticalなどがあります。Heron Therapeutics, Inc.、Qilu Pharmaceuticalは上位3社で、2022年の売上高シェアは合計で%でした。
アプレピタント注射剤は、注射剤と注射ローション剤などに分けられます。注射剤は市場の主流製品であり、2022年の世界売上高シェアは注射剤が占める。
Aprepitant注射剤は癌治療センター、病院など様々な分野で広く使われている。癌治療センターはAprepitant Injection産業の発展に最大のサポートを提供する。2022年、Aprepitant注射剤の世界売上シェアは癌治療センターが占める。

レポートの範囲
本レポートは、過去の分析(2018-2022年)と予測計算(2023-2029年)に基づき、読者が世界のアプレピタント注市場を多角的に包括的に理解することを目的とし、読者の戦略と意思決定に十分なサポートを提供します。

レポート掲載メーカー、タイプ、用途、地域
企業別
ヘロン・セラピューティクス社
Qilu Pharmaceutical
タイプ別
注射剤
注射ローション
用途別セグメント
癌治療センター
病院
地域別セグメント
北米
米国
カナダ
欧州
ドイツ
フランス
英国
イタリア
ロシア
アジア太平洋
中国
日本
韓国
インド
オーストラリア
中国 台湾
東南アジア
ラテンアメリカ
メキシコ
ブラジル
アルゼンチン
中東・アフリカ
トルコ
サウジアラビア
アラブ首長国連邦

本レポートの各章は、読者がアプレピタント注射剤市場をさらに理解するための詳細な情報を提供します:
第1章:2018年から2023年までの北米、欧州、アジア太平洋、中南米、中東およびアフリカにおける製品定義、製品タイプ、各タイプの数量および収益分析。
第2章:売上高と収益の比較を含むメーカーの競争状況、Aprepitant Injectionのメーカーの商業日、各メーカーが提供する製品タイプ、M&A活動、Aprepitant Injection業界で発生した拡張活動。
第3章:北米、欧州、アジア太平洋、中南米、中東、アフリカにおけるアプレピタント注射剤の過去(2018年-2022年)および予測(2023年-2029年)の数量と収益分析。
第4章:2018年から2023年までの北米、欧州、アジア太平洋、ラテンアメリカ、中東およびアフリカにおける製品用途、各用途の数量および収益分析。
第5章から第9章:北米、欧州、アジア太平洋、ラテンアメリカ、中東およびアフリカの国別レベル分析、数量および収益分析を含む。
第10章:メーカー概要:本社、連絡先、主要事業、アプレピタント注射剤の紹介など、企業の基本情報を網羅する。また、各社の売上高、収益、価格、グロスマージン、最近の動向もこの部分に含まれています。
第11章:原材料、製造コストのような産業チェーンがカバーされています。加えて、市場機会と課題もこの章で強調されている。
第12章:市場チャネル、流通業者と顧客がリストアップされています。
第13章包括的な調査に基づくアプレピタント注射剤市場のQYResearchの結論。
第14章:QYResearchが採用した方法論とデータソース。


ページTOPに戻る


目次

1 Aprepitant Injection Market Overview
1.1 Aprepitant Injection Product Overview
1.2 Aprepitant Injection Market Segment by Type
1.2.1 Injection
1.2.2 Injection Lotion
1.3 Global Aprepitant Injection Market Size by Type
1.3.1 Global Aprepitant Injection Market Size Overview by Type (2018-2029)
1.3.2 Global Aprepitant Injection Historic Market Size Review by Type (2018-2023)
1.3.3 Global Aprepitant Injection Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Aprepitant Injection Sales Breakdown by Type (2018-2023)
1.4.2 Europe Aprepitant Injection Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Aprepitant Injection Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Aprepitant Injection Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Aprepitant Injection Sales Breakdown by Type (2018-2023)
2 Global Aprepitant Injection Market Competition by Company
2.1 Global Top Players by Aprepitant Injection Sales (2018-2023)
2.2 Global Top Players by Aprepitant Injection Revenue (2018-2023)
2.3 Global Top Players by Aprepitant Injection Price (2018-2023)
2.4 Global Top Manufacturers Aprepitant Injection Manufacturing Base Distribution, Sales Area, Product Type
2.5 Aprepitant Injection Market Competitive Situation and Trends
2.5.1 Aprepitant Injection Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Aprepitant Injection Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Aprepitant Injection as of 2022)
2.7 Date of Key Manufacturers Enter into Aprepitant Injection Market
2.8 Key Manufacturers Aprepitant Injection Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Aprepitant Injection Status and Outlook by Region
3.1 Global Aprepitant Injection Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Aprepitant Injection Historic Market Size by Region
3.2.1 Global Aprepitant Injection Sales in Volume by Region (2018-2023)
3.2.2 Global Aprepitant Injection Sales in Value by Region (2018-2023)
3.2.3 Global Aprepitant Injection Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Aprepitant Injection Forecasted Market Size by Region
3.3.1 Global Aprepitant Injection Sales in Volume by Region (2024-2029)
3.3.2 Global Aprepitant Injection Sales in Value by Region (2024-2029)
3.3.3 Global Aprepitant Injection Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Aprepitant Injection by Application
4.1 Aprepitant Injection Market Segment by Application
4.1.1 Cancer Treatment Center
4.1.2 Hospital
4.2 Global Aprepitant Injection Market Size by Application
4.2.1 Global Aprepitant Injection Market Size Overview by Application (2018-2029)
4.2.2 Global Aprepitant Injection Historic Market Size Review by Application (2018-2023)
4.2.3 Global Aprepitant Injection Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Aprepitant Injection Sales Breakdown by Application (2018-2023)
4.3.2 Europe Aprepitant Injection Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Aprepitant Injection Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Aprepitant Injection Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Aprepitant Injection Sales Breakdown by Application (2018-2023)
5 North America Aprepitant Injection by Country
5.1 North America Aprepitant Injection Historic Market Size by Country
5.1.1 North America Aprepitant Injection Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Aprepitant Injection Sales in Volume by Country (2018-2023)
5.1.3 North America Aprepitant Injection Sales in Value by Country (2018-2023)
5.2 North America Aprepitant Injection Forecasted Market Size by Country
5.2.1 North America Aprepitant Injection Sales in Volume by Country (2024-2029)
5.2.2 North America Aprepitant Injection Sales in Value by Country (2024-2029)
6 Europe Aprepitant Injection by Country
6.1 Europe Aprepitant Injection Historic Market Size by Country
6.1.1 Europe Aprepitant Injection Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Aprepitant Injection Sales in Volume by Country (2018-2023)
6.1.3 Europe Aprepitant Injection Sales in Value by Country (2018-2023)
6.2 Europe Aprepitant Injection Forecasted Market Size by Country
6.2.1 Europe Aprepitant Injection Sales in Volume by Country (2024-2029)
6.2.2 Europe Aprepitant Injection Sales in Value by Country (2024-2029)
7 Asia-Pacific Aprepitant Injection by Region
7.1 Asia-Pacific Aprepitant Injection Historic Market Size by Region
7.1.1 Asia-Pacific Aprepitant Injection Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Aprepitant Injection Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Aprepitant Injection Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Aprepitant Injection Forecasted Market Size by Region
7.2.1 Asia-Pacific Aprepitant Injection Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Aprepitant Injection Sales in Value by Region (2024-2029)
8 Latin America Aprepitant Injection by Country
8.1 Latin America Aprepitant Injection Historic Market Size by Country
8.1.1 Latin America Aprepitant Injection Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Aprepitant Injection Sales in Volume by Country (2018-2023)
8.1.3 Latin America Aprepitant Injection Sales in Value by Country (2018-2023)
8.2 Latin America Aprepitant Injection Forecasted Market Size by Country
8.2.1 Latin America Aprepitant Injection Sales in Volume by Country (2024-2029)
8.2.2 Latin America Aprepitant Injection Sales in Value by Country (2024-2029)
9 Middle East and Africa Aprepitant Injection by Country
9.1 Middle East and Africa Aprepitant Injection Historic Market Size by Country
9.1.1 Middle East and Africa Aprepitant Injection Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Aprepitant Injection Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Aprepitant Injection Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Aprepitant Injection Forecasted Market Size by Country
9.2.1 Middle East and Africa Aprepitant Injection Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Aprepitant Injection Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Heron Therapeutics, Inc.
10.1.1 Heron Therapeutics, Inc. Company Information
10.1.2 Heron Therapeutics, Inc. Introduction and Business Overview
10.1.3 Heron Therapeutics, Inc. Aprepitant Injection Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Heron Therapeutics, Inc. Aprepitant Injection Products Offered
10.1.5 Heron Therapeutics, Inc. Recent Development
10.2 Qilu Pharmaceutical
10.2.1 Qilu Pharmaceutical Company Information
10.2.2 Qilu Pharmaceutical Introduction and Business Overview
10.2.3 Qilu Pharmaceutical Aprepitant Injection Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Qilu Pharmaceutical Aprepitant Injection Products Offered
10.2.5 Qilu Pharmaceutical Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Aprepitant Injection Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Aprepitant Injection Industrial Chain Analysis
11.4 Aprepitant Injection Market Dynamics
11.4.1 Aprepitant Injection Industry Trends
11.4.2 Aprepitant Injection Market Drivers
11.4.3 Aprepitant Injection Market Challenges
11.4.4 Aprepitant Injection Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Aprepitant Injection Distributors
12.3 Aprepitant Injection Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

 

ページTOPに戻る


 

Summary

Arepidan injection is a submicron emulsion prepared by wrapping Arepidan in soybean oil. Compared with oral preparation, it can significantly improve the bioavailability and drug compliance; At the same time, it can effectively reduce the incidence of anaphylaxis in the clinical use of similar injection preparations. It is a prescription drug for the treatment of nausea and vomiting caused by chemotherapy. It can be used alone or together with other drugs.

Aprepitant Injection report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Aprepitant Injection market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Demand from Cancer Treatment Center and Hospital are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Aprepitant Injection industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2029.

Globally, Aprepitant Injection key manufacturers include Heron Therapeutics, Inc. and Qilu Pharmaceutical etc. Heron Therapeutics, Inc., Qilu Pharmaceutical, are top 3 players and held % sales share in total in 2022.
Aprepitant Injection can be divided into Injection and Injection Lotion, etc. Injection is the mainstream product in the market, accounting for % sales share globally in 2022.
Aprepitant Injection is widely used in various fields, such as Cancer Treatment Center and Hospital, etc. Cancer Treatment Center provides greatest supports to the Aprepitant Injection industry development. In 2022, global % sales of Aprepitant Injection went into Cancer Treatment Center filed.

Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Aprepitant Injection market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

Manufacturers, Type, Application and Regions Listed in the Report:
By Company
Heron Therapeutics, Inc.
Qilu Pharmaceutical
Segment by Type
Injection
Injection Lotion
Segment by Application
Cancer Treatment Center
Hospital
Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Each chapter of the report provides detailed information for readers to understand the Aprepitant Injection market further:
Chapter 1: Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 2: Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Aprepitant Injection, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Aprepitant Injection industry.
Chapter 3: Historical (2018-2022) and forecast (2023-2029) volume and revenue analysis of Aprepitant Injection in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4: Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 5 to 9: Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10: Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Aprepitant Injection introduction, etc. Aprepitant Injection Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11: Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12: Market Channel, Distributors and Customers are listed.
Chapter 13: QYResearch’s Conclusions of Aprepitant Injection market based on comprehensive survey.
Chapter 14: Methodology and Data Sources adopted by QYResearch.



ページTOPに戻る


Table of Contents

1 Aprepitant Injection Market Overview
1.1 Aprepitant Injection Product Overview
1.2 Aprepitant Injection Market Segment by Type
1.2.1 Injection
1.2.2 Injection Lotion
1.3 Global Aprepitant Injection Market Size by Type
1.3.1 Global Aprepitant Injection Market Size Overview by Type (2018-2029)
1.3.2 Global Aprepitant Injection Historic Market Size Review by Type (2018-2023)
1.3.3 Global Aprepitant Injection Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Aprepitant Injection Sales Breakdown by Type (2018-2023)
1.4.2 Europe Aprepitant Injection Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Aprepitant Injection Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Aprepitant Injection Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Aprepitant Injection Sales Breakdown by Type (2018-2023)
2 Global Aprepitant Injection Market Competition by Company
2.1 Global Top Players by Aprepitant Injection Sales (2018-2023)
2.2 Global Top Players by Aprepitant Injection Revenue (2018-2023)
2.3 Global Top Players by Aprepitant Injection Price (2018-2023)
2.4 Global Top Manufacturers Aprepitant Injection Manufacturing Base Distribution, Sales Area, Product Type
2.5 Aprepitant Injection Market Competitive Situation and Trends
2.5.1 Aprepitant Injection Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Aprepitant Injection Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Aprepitant Injection as of 2022)
2.7 Date of Key Manufacturers Enter into Aprepitant Injection Market
2.8 Key Manufacturers Aprepitant Injection Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Aprepitant Injection Status and Outlook by Region
3.1 Global Aprepitant Injection Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Aprepitant Injection Historic Market Size by Region
3.2.1 Global Aprepitant Injection Sales in Volume by Region (2018-2023)
3.2.2 Global Aprepitant Injection Sales in Value by Region (2018-2023)
3.2.3 Global Aprepitant Injection Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Aprepitant Injection Forecasted Market Size by Region
3.3.1 Global Aprepitant Injection Sales in Volume by Region (2024-2029)
3.3.2 Global Aprepitant Injection Sales in Value by Region (2024-2029)
3.3.3 Global Aprepitant Injection Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Aprepitant Injection by Application
4.1 Aprepitant Injection Market Segment by Application
4.1.1 Cancer Treatment Center
4.1.2 Hospital
4.2 Global Aprepitant Injection Market Size by Application
4.2.1 Global Aprepitant Injection Market Size Overview by Application (2018-2029)
4.2.2 Global Aprepitant Injection Historic Market Size Review by Application (2018-2023)
4.2.3 Global Aprepitant Injection Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Aprepitant Injection Sales Breakdown by Application (2018-2023)
4.3.2 Europe Aprepitant Injection Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Aprepitant Injection Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Aprepitant Injection Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Aprepitant Injection Sales Breakdown by Application (2018-2023)
5 North America Aprepitant Injection by Country
5.1 North America Aprepitant Injection Historic Market Size by Country
5.1.1 North America Aprepitant Injection Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Aprepitant Injection Sales in Volume by Country (2018-2023)
5.1.3 North America Aprepitant Injection Sales in Value by Country (2018-2023)
5.2 North America Aprepitant Injection Forecasted Market Size by Country
5.2.1 North America Aprepitant Injection Sales in Volume by Country (2024-2029)
5.2.2 North America Aprepitant Injection Sales in Value by Country (2024-2029)
6 Europe Aprepitant Injection by Country
6.1 Europe Aprepitant Injection Historic Market Size by Country
6.1.1 Europe Aprepitant Injection Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Aprepitant Injection Sales in Volume by Country (2018-2023)
6.1.3 Europe Aprepitant Injection Sales in Value by Country (2018-2023)
6.2 Europe Aprepitant Injection Forecasted Market Size by Country
6.2.1 Europe Aprepitant Injection Sales in Volume by Country (2024-2029)
6.2.2 Europe Aprepitant Injection Sales in Value by Country (2024-2029)
7 Asia-Pacific Aprepitant Injection by Region
7.1 Asia-Pacific Aprepitant Injection Historic Market Size by Region
7.1.1 Asia-Pacific Aprepitant Injection Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Aprepitant Injection Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Aprepitant Injection Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Aprepitant Injection Forecasted Market Size by Region
7.2.1 Asia-Pacific Aprepitant Injection Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Aprepitant Injection Sales in Value by Region (2024-2029)
8 Latin America Aprepitant Injection by Country
8.1 Latin America Aprepitant Injection Historic Market Size by Country
8.1.1 Latin America Aprepitant Injection Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Aprepitant Injection Sales in Volume by Country (2018-2023)
8.1.3 Latin America Aprepitant Injection Sales in Value by Country (2018-2023)
8.2 Latin America Aprepitant Injection Forecasted Market Size by Country
8.2.1 Latin America Aprepitant Injection Sales in Volume by Country (2024-2029)
8.2.2 Latin America Aprepitant Injection Sales in Value by Country (2024-2029)
9 Middle East and Africa Aprepitant Injection by Country
9.1 Middle East and Africa Aprepitant Injection Historic Market Size by Country
9.1.1 Middle East and Africa Aprepitant Injection Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Aprepitant Injection Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Aprepitant Injection Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Aprepitant Injection Forecasted Market Size by Country
9.2.1 Middle East and Africa Aprepitant Injection Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Aprepitant Injection Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Heron Therapeutics, Inc.
10.1.1 Heron Therapeutics, Inc. Company Information
10.1.2 Heron Therapeutics, Inc. Introduction and Business Overview
10.1.3 Heron Therapeutics, Inc. Aprepitant Injection Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Heron Therapeutics, Inc. Aprepitant Injection Products Offered
10.1.5 Heron Therapeutics, Inc. Recent Development
10.2 Qilu Pharmaceutical
10.2.1 Qilu Pharmaceutical Company Information
10.2.2 Qilu Pharmaceutical Introduction and Business Overview
10.2.3 Qilu Pharmaceutical Aprepitant Injection Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Qilu Pharmaceutical Aprepitant Injection Products Offered
10.2.5 Qilu Pharmaceutical Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Aprepitant Injection Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Aprepitant Injection Industrial Chain Analysis
11.4 Aprepitant Injection Market Dynamics
11.4.1 Aprepitant Injection Industry Trends
11.4.2 Aprepitant Injection Market Drivers
11.4.3 Aprepitant Injection Market Challenges
11.4.4 Aprepitant Injection Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Aprepitant Injection Distributors
12.3 Aprepitant Injection Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野(データ解析)の最新刊レポート


よくあるご質問


QYResearch社はどのような調査会社ですか?


QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。   QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/11/08 10:26

154.13 円

166.76 円

202.76 円

ページTOPに戻る